Edition:
United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

67.31USD
28 Sep 2016
Change (% chg)

-- (--)
Prev Close
$67.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
215,552
52-wk High
$69.00
52-wk Low
$36.81

Latest Key Developments (Source: Significant Developments)

NuVasive - sees 2016 revenue of approximately $962 mln
Tuesday, 26 Jul 2016 04:02pm EDT 

NuVasive Inc : FY2016 earnings per share view $1.51, revenue view $936.0 million -- Thomson Reuters I/B/E/S . NuVasive reports second quarter 2016 financial results . Q2 non-GAAP earnings per share $0.40 . Q2 GAAP earnings per share $0.57 . Q2 revenue rose 16.4 percent to $236.2 million . Sees 2016 revenue of approximately $962.0 million . Sees 2016 non-GAAP diluted earnings per share of approximately $1.64 .Sees 2016 non-GAAP operating profit margin of approximately 16.0 pct.  Full Article

Nuvasive agrees to settle patent litigation with Medtronic
Thursday, 30 Jun 2016 04:05pm EDT 

Nuvasive Inc : Nuvasive agrees to settle patent litigation with Medtronic . Nuvasive and Medtronic reached agreement on terms for settlement of previously disclosed patent infringement lawsuits . Company and Medtronic intend to enter into a definitive settlement agreement within 15 days . Reached agreement on terms for withdrawal from proceedings in United States patent and trademark office . After settlement agreement, company will make a one-time payment of $45 million to medtronic .Parties will release each other from any and all liabilities arising out of litigation.  Full Article

NuVasive to acquire Biotronic NeuroNetwork
Monday, 6 Jun 2016 04:05pm EDT 

NuVasive Inc : NuVasive to acquire Biotronic NeuroNetwork . Deal for $98 million . Board of directors of both companies have unanimously approved transaction . Deal immediately accretive to non-GAAP diluted earnings, aligned to operating and EBITDA margin expansion . NuVasive expects to fund acquisition with existing cash on hand .NuVasive expects transaction to be significantly accretive in 2017 and beyond.  Full Article

NuVasive Inc announces proposed offering of $550 million of convertible senior notes due 2021
Wednesday, 9 Mar 2016 04:05pm EST 

NuVasive Inc:Announces proposed offering of $550 million of convertible senior notes due 2021.  Full Article

NuVasive to acquire Ellipse Technologies
Tuesday, 5 Jan 2016 04:15pm EST 

NuVasive Inc :To acquire ellipse technologies.Nuvasive will acquire Ellipse for a $380 million upfront cash payment and a potential $30 million milestone payable in 2017.Expects the acquisition to accelerate its revenue growth toward the high-single digit range.Sees deal to be slightly accretive to the company's non-GAAP diluted earnings per share within the first 12 months.Also expects the transaction to support its five-year, double-digit return on invested capital goal".Nuvasive expects to fund the acquisition with existing cash on hand.  Full Article

NuVasive reaffirms FY 2015 revenue guidance; raises FY 2015 EPS guidance
Tuesday, 27 Oct 2015 04:05pm EDT 

NuVasive Inc:Sees FY 2015 revenue of approximately $810.0 million.Sees FY 2015 GAAP diluted earnings per share of approximately $1.24 compared to GAAP loss per diluted share of $(0.36) for 2014; versus a prior expectation of $1.18 for 2015.Sees FY 2015 Non-GAAP diluted earnings per share of approximately $1.25, an increase of approximately 86.6% compared to non-GAAP diluted earnings of $0.67 for 2014; versus a prior expectation of $1.17 for 2015.FY 2015 revenue of $813 million and EPS of $1.20 - Thomson Reuters I/B/E/S.  Full Article

NuVasive reaffirms FY 2015 revenue outlook; raises FY 2015 EPS outlook
Tuesday, 28 Jul 2015 04:05pm EDT 

NuVasive Inc:Projects FY 2015 revenue guidance of approximately $810.0 million.Projects FY 2015 GAAP earnings per share of approximately $1.18.Projects FY 2015 Non-GAAP earnings per share of approximately $1.17.FY 2015 revenue of $812 million and EPS of $1.12 - Thomson Reuters I/B/E/S.  Full Article

NuVasive appoints Gregory T. Lucier Chief Executive Officer
Tuesday, 26 May 2015 08:30am EDT 

NuVasive:Says Gregory T. Lucier has been appointed Chief Executive Officer, effective immediately.Lucier, who has been serving as Interim Chief Executive Officer since April 1, 2015, will continue as Chairman of the NuVasive Board of Directors.  Full Article

NuVasive Inc reaffirms FY 2015 outlook
Monday, 4 May 2015 04:05pm EDT 

NuVasive Inc:Updates FY 2015 revenue of about $810.0 mln, which includes an about $12.0 mln of currency headwinds versus a prior expectation of an about $10.0 mln currency impact for FY 2015, or about 6.0 pct.Raises FY 2015 GAAP earnings per share of about $1.12 (prior range of $0.67).Updates FY 2015 Non-GAAP earnings per share of about $1.10.  Full Article

NuVasive Inc announces resignation of CEO and Chairman - Form 8-K
Wednesday, 1 Apr 2015 08:36am EDT 

NuVasive Inc:Says On March 28 Alex V. Lukianov, the Chief Executive Officer and the Chairman of the Board of the Company and a member of its Board of Directors, resigned as Chairman, Chief Executive Officer, and as a member of the Board and all other positions he had with the Company subsidiaries and affiliates.Effective March 27.Lukianov will remain with the Company as a consultant to assist with the transition and serve as a special advisor to the successor Chief Executive Officer through Sept. 30, 2016.  Full Article

BRIEF-NuVasive receives FDA 510(k)clearance

* Receives FDA 510(k) clearance reinforcing comprehensive portfolio supporting pediatric, adolescent and adult spinal deformity patients Source text for Eikon: Further company coverage: